<div id="readability-page-1"><p>Amundi raised its holdings in shares of  The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 35.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The fund owned 1,331,480 shares of the medical device company's stock after buying an additional 348,652 shares during the quarter. Amundi owned about 0.67% of Cooper Companies worth $97,225,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Cooper Companies</strong> alerts:</span></p></div><ul><li>This ETF Weeds Out Small-Cap Underperformers</li></ul><p>Other hedge funds also recently modified their holdings of the company. Horizon Investments LLC increased its position in  Cooper Companies by 5.0% during the first quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after acquiring an additional 136 shares during the period.  Wealth Alliance LLC grew its position in  Cooper Companies by 4.2% in the 2nd quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company's stock worth $301,000 after purchasing an additional 171 shares during the last quarter.  State of Michigan Retirement System increased its holdings in shares of  Cooper Companies by 0.4% during the 2nd quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company's stock worth $3,867,000 after purchasing an additional 200 shares during the period.  New York Life Investment Management LLC raised its position in shares of  Cooper Companies by 0.7% during the second quarter. New York Life Investment Management LLC now owns 30,019 shares of the medical device company's stock valued at $2,136,000 after buying an additional 210 shares during the last quarter.  Finally, EverSource Wealth Advisors LLC lifted its stake in shares of  Cooper Companies by 3.5% in the first quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company's stock valued at $550,000 after buying an additional 220 shares during the period. 24.39% of the stock is owned by institutional investors. </p><h2>Analysts Set New Price Targets</h2><p>Several equities analysts recently issued reports on the company. Wells Fargo &amp; Company boosted their price target on Cooper Companies from $72.00 to $82.00 and gave the company an &#34;equal weight&#34; rating in a research note on Friday. JPMorgan Chase &amp; Co. lifted their price objective on Cooper Companies from $66.00 to $78.00 and gave the stock a &#34;neutral&#34; rating in a report on Friday. Barclays started coverage on Cooper Companies in a research note on Monday, October 13th. They issued an &#34;overweight&#34; rating and a $85.00 target price for the company. Robert W. Baird lifted their price target on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an &#34;outperform&#34; rating in a research note on Friday. Finally, KeyCorp  restated a &#34;sector weight&#34; rating on shares of Cooper Companies in a research note on Friday. One analyst  has rated the stock with a Strong Buy rating, nine have assigned  a Buy rating, five have issued  a Hold rating and one  has assigned  a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $90.31.</p><ul><li>Analysts Love These 3 Companies Reporting Earnings This Week</li></ul><p><b>Get Our Latest Stock Report on COO</b></p><h2>Insider Buying and Selling at Cooper Companies</h2><p>In other Cooper Companies news, Director Lawrence Erik Kurzius purchased 2,000 shares of the business's stock in a transaction that occurred on Monday, September 29th. The stock was acquired at an average cost of $68.39 per share, with a total value of $136,780.00. Following the completion of the acquisition, the director directly owned 5,777 shares of the company's stock, valued at $395,089.03. This represents a 52.95% increase in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this hyperlink. Company insiders own  1.98% of the company's stock. </p><h2>Cooper Companies Stock Performance</h2><ul><li>3 Oversold Stocks Flashing Bullish Reversal Signals</li></ul><p>NASDAQ:COO opened at $81.40 on Monday. The stock has a market capitalization of $16.18 billion, a P/E ratio of 43.30, a price-to-earnings-growth ratio of 1.94 and a beta of 1.05. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $101.53. The firm has a 50 day moving average of $72.29 and a 200-day moving average of $71.61. </p><p>Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the company earned $1.04 EPS. Cooper Companies's revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS.  As a group, sell-side analysts anticipate that  The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year. </p><p>Cooper Companies declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, September 17th that permits the company to buyback $2.00 billion in  outstanding  shares. This buyback authorization permits the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's leadership believes its stock is undervalued. </p><h2>Cooper Companies Company Profile</h2> (Free Report)<p>The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Cooper Companies</li><li>What is a Bond Market Holiday? How to Invest and Trade</li><li>Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast</li><li>How to Short a Stock in 5 Easy Steps </li><li>Five Below and Dollar Tree Earnings Signal a Shopper Shift</li><li>What Is WallStreetBets and What Stocks Are They Targeting?</li><li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q09P?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q09P"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Cooper Companies Right Now?</h2><p>Before you consider Cooper Companies, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.</p><p>While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Amundi increased its stake in The Cooper Companies, Inc. by 35.5% in Q2, acquiring 348,652 shares. Analysts have set new price targets, with Wells Fargo raising it to $82 and JPMorgan to $78. The stock has an average rating of "Moderate Buy" and a target of $90.31. Cooper Companies' stock opened at $81.40, with a market cap of $16.18 billion.</p>

Amundi Acquires 348,652 Shares of The Cooper Companies, Inc. $COO